Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Patient Recruitment Resumes in FibroGen Phase 2 Study of Investigational Oral HIF-PH Inhibitor, FG-4592/ASP1517, for ... (Business Wire via Yahoo! Finance) |
SAN FRANCISCO----FibroGen, Inc. today announced that patient recruitment has resumed in a phase 2 study of FG-4592/ASP1517, an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor in development for the treatment of anemia associated with chronic kidney disease . |